NLM Digital Collections

Search

Start Over Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation

281. Substance use disorder: reliable data needed for Substance Abuse Prevention and Treatment Block Grant Program : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2020
Subject(s):
Government Regulation
Health Services Needs and Demand -- legislation & jurisprudence
Substance Abuse Treatment Centers -- legislation & jurisprudence
United States

282. Tribal programs: resource constraints and management weaknesses can limit federal program delivery to tribes : testimony before the Subcommittee for Indigenous Peoples of the United States, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, November 19, 2019
Subject(s):
American Natives -- legislation & jurisprudence
Government Regulation
Minority Health -- economics
Population Groups -- legislation & jurisprudence
United States

283. Medicare severe wound care: spending declines may reflect site of care changes; limited information is available on quality : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, January 2021
Subject(s):
Government Regulation
Economics, Hospital
Long-Term Care -- economics
Medicare -- economics
Pressure Ulcer -- rehabilitation
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

284. Generic drug development: stakeholders’ views of risk evaluation and mitigation strategies differ : report to the Chairman, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 2019
Subject(s):
Drug Industry -- legislation & jurisprudence
Drugs, Generic -- isolation & purification
Government Regulation
Risk Evaluation and Mitigation -- legislation & jurisprudence
United States
United States. Food and Drug Administration

285. Mental health and substance use: state and federal oversight of compliance with parity requirements varies : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2019
Subject(s):
Drug Users -- legislation & jurisprudence
Government Regulation
Healthcare Disparities -- legislation & jurisprudence
Mental Health Services -- legislation & jurisprudence
Substance-Related Disorders
United States
United States. Department of Health and Human Services
United States.

286. Medicaid: state views on program administration challenges : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, April 2020
Subject(s):
Drug Users -- legislation & jurisprudence
Government Regulation
Healthcare Disparities -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Substance-Related Disorders
United States
Centers for Medicare & Medicaid Services (U.S.)

287. Medicaid: states' changes to payment rates for substance use disorder services : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, January 2020
Subject(s):
Drug Users -- legislation & jurisprudence
Government Regulation
Healthcare Disparities -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Reimbursement, Disproportionate Share
Substance-Related Disorders
United States
Centers for Medicare & Medicaid Services (U.S.)

288. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, June 23, 2020
Subject(s):
Air Travel
Communicable Diseases -- transmission
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Travel-Related Illness
COVID-19 -- transmission
United States

289. Clinical labs: studies suggest biopsy specimen misidentification and contamination errors are infrequent : report to the Ranking Member, Committee on Finance, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, November 2020
Subject(s):
Clinical Laboratory Techniques -- standards
Diagnostic Errors -- legislation & jurisprudence
Government Regulation
Specimen Handling -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

290. Drug misuse: sustained national efforts are necessary for prevention, response, and recovery : report to the Congress

Publication:
Washington, DC : United States Government Accountability Office, March 2020
Subject(s):
Drug Misuse -- trends
Drug Overdose -- prevention & control
Government Regulation
Substance-Related Disorders -- prevention & control
United States
United States. Substance Abuse and Mental Health Services Administration